Your browser doesn't support javascript.
loading
International rare donor panels: a review.
Nance, S; Scharberg, E A; Thornton, N; Yahalom, V; Sareneva, I; Lomas-Francis, C.
Affiliation
  • Nance S; IRL, Biomedical Services, American Red Cross, Philadelphia, PA, USA.
  • Scharberg EA; Institute for Transfusion Medicine and Immunohematology, Red Cross Transfusion Service of Baden-Wuerttemberg-Hessen gGmbH, Baden-Baden, Germany.
  • Thornton N; The International Blood Group Reference Laboratory, NHS Blood and Transplant, Filton, Bristol, UK.
  • Yahalom V; National Blood Services, Ramat Gan, Israel.
  • Sareneva I; Blood Group Unit, Finnish Red Cross Blood Service, Helsinki, Finland.
  • Lomas-Francis C; New York Blood Center, Laboratory of Immunohematology and Genomics, Long Island City, NY, USA.
Vox Sang ; 110(3): 209-18, 2016 Apr.
Article in En | MEDLINE | ID: mdl-26689301
ABSTRACT
International rare blood donor panels or registries are important in the consistent availability of rare blood for patients who need this scarce resource. In countries where it has been possible to commit resources to this effort and often where the need is great, donors have been entered into a registry. The ISBT leadership recognized the importance of this very challenging inventory management activity and created a Working Party to support it. Individual countries support the WHO International Rare Donor Panel by submitting their donors' phenotype or genotype information to be catalogued into the database. It is extremely important that this database be cultivated and grown. The contributing countries keep their list updated and supply the blood product as they can when requested. It is known that some blood types are extremely scarce worldwide and requests for these are particularly difficult to fulfil. Thus, it is important to have a protocol to identify and recruit donors with rare blood types. It is equally or perhaps more important to ensure that the patients who need the rare blood are being managed appropriately in the presence and absence of rare blood products being available.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Health context: 2_ODS3 Database: MEDLINE Main subject: International Agencies / Blood Donors Limits: Humans Language: En Journal: Vox Sang Year: 2016 Document type: Article

Full text: 1 Collection: 01-internacional Health context: 2_ODS3 Database: MEDLINE Main subject: International Agencies / Blood Donors Limits: Humans Language: En Journal: Vox Sang Year: 2016 Document type: Article